MarketCap
Facebook
X
TelegramObalon Therapeutics, Inc. ROE Ratio 2011-2026 | OBLN
Annual ROE Ratio Obalon Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -264.39 | -149.38 | -285.19 | -99.01 | -31.83 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -31.83 | -285.19 | -165.96 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
16.96 | - | - | $ 17.2 B |  USA |
 |
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
1144.21 | $ 21.04 | 0.86 % | $ 3.01 B | USA |
 |
Acutus Medical
AFIB
|
9290.44 | - | -26.83 % | $ 2.62 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
-70.08 | $ 3.5 | 1.74 % | $ 121 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-6.08 | $ 9.4 | 1.08 % | $ 675 M |  Israel |
 |
Boston Scientific Corporation
BSX
|
8.48 | $ 95.35 | -0.69 % | $ 140 B | USA |
 |
Bio-Rad Laboratories
BIO
|
-10.9 | $ 302.99 | -0.5 % | $ 8.55 B | USA |
 |
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | USA |
 |
BioSig Technologies
BSGM
|
669.04 | - | 37.08 % | $ 85.7 M | USA |
 |
Cutera
CUTR
|
33.31 | - | -10.19 % | $ 1.99 M | USA |
 |
Bruker Corporation
BRKR
|
6.35 | $ 47.11 | -0.84 % | $ 7.02 K | USA |
 |
Electromed
ELMD
|
17.44 | $ 29.12 | 1.01 % | $ 246 M | USA |
 |
Abbott Laboratories
ABT
|
28.12 | $ 125.29 | -0.39 % | $ 218 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-46.5 | $ 3.29 | 2.49 % | $ 123 M |  France |
 |
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | USA |
 |
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-1451.06 | - | - | $ 111 M |  Canada |
 |
IRadimed Corporation
IRMD
|
22.15 | $ 97.28 | -0.5 % | $ 1.23 B | USA |
 |
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | USA |
 |
Zynex
ZYXI
|
8.38 | - | - | $ 21.1 M | USA |
 |
InMode Ltd.
INMD
|
25.76 | $ 14.69 | -1.01 % | $ 1.17 B | Israel |
 |
Second Sight Medical Products
EYES
|
-133.37 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
10.94 | $ 156.15 | -1.26 % | $ 11.7 B | USA |
 |
Accuray Incorporated
ARAY
|
-1.96 | $ 0.82 | 2.64 % | $ 84.3 M | USA |
 |
LivaNova PLC
LIVN
|
4.79 | $ 61.53 | -1.2 % | $ 3.34 B |  Britain |
|
LENSAR
LNSR
|
-645.91 | $ 11.63 | - | $ 134 M | USA |
 |
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-74.5 | $ 13.68 | 0.81 % | $ 370 M | USA |
 |
FONAR Corporation
FONR
|
8.28 | $ 18.56 | -0.22 % | $ 122 M | USA |
 |
AxoGen
AXGN
|
-9.59 | $ 32.73 | - | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-10.47 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
-100.5 | $ 1.14 | -0.87 % | $ 18.4 M | USA |
 |
CONMED Corporation
CNMD
|
13.76 | $ 40.6 | -1.31 % | $ 1.25 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-10.67 | $ 17.76 | -1.11 % | $ 410 M | USA |
 |
Myomo
MYO
|
-168.59 | $ 0.91 | -1.58 % | $ 6.42 M | USA |
 |
Globus Medical
GMED
|
2.47 | $ 87.31 | -0.68 % | $ 11.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.45 | $ 12.42 | -2.05 % | $ 956 M | USA |